Holly Rawizza

454 total citations
22 papers, 332 citations indexed

About

Holly Rawizza is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Holly Rawizza has authored 22 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 10 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Holly Rawizza's work include HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (12 papers) and HIV Research and Treatment (10 papers). Holly Rawizza is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (12 papers) and HIV Research and Treatment (10 papers). Holly Rawizza collaborates with scholars based in United States, Nigeria and South Africa. Holly Rawizza's co-authors include Seema Meloni, Prosper Okonkwo, Phyllis J. Kanki, Charlotte A. Chang, Beth Chaplin, Beth Chaplin, Geoffrey Eisen, Oche Agbaji, Bolanle Banigbe and Obinna Onwujekwe and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Holly Rawizza

18 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holly Rawizza United States 8 313 174 112 45 28 22 332
Yao Abo Ivory Coast 6 229 0.7× 93 0.5× 135 1.2× 18 0.4× 19 0.7× 12 265
Zhongfu Liu China 10 297 0.9× 160 0.9× 168 1.5× 33 0.7× 22 0.8× 42 345
Sophie Karcher France 6 261 0.8× 121 0.7× 105 0.9× 36 0.8× 40 1.4× 9 289
Khine Wut Yee Kyaw Myanmar 10 205 0.7× 60 0.3× 148 1.3× 44 1.0× 23 0.8× 35 273
Tinei Shamu Zimbabwe 12 239 0.8× 141 0.8× 76 0.7× 27 0.6× 17 0.6× 41 320
Lameck Luwanda Tanzania 7 208 0.7× 91 0.5× 81 0.7× 64 1.4× 33 1.2× 16 226
Charity Alfredo Mozambique 7 189 0.6× 77 0.4× 105 0.9× 28 0.6× 43 1.5× 7 213
Boniface Dongmo Nguimfack Switzerland 8 221 0.7× 117 0.7× 180 1.6× 21 0.5× 17 0.6× 9 345
Fatima Sall United States 11 259 0.8× 161 0.9× 77 0.7× 58 1.3× 7 0.3× 18 335
K. Naidu South Africa 10 221 0.7× 102 0.6× 131 1.2× 64 1.4× 32 1.1× 17 289

Countries citing papers authored by Holly Rawizza

Since Specialization
Citations

This map shows the geographic impact of Holly Rawizza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Rawizza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Rawizza more than expected).

Fields of papers citing papers by Holly Rawizza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Rawizza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Rawizza. The network helps show where Holly Rawizza may publish in the future.

Co-authorship network of co-authors of Holly Rawizza

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Rawizza. A scholar is included among the top collaborators of Holly Rawizza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Rawizza. Holly Rawizza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Charlotte A., et al.. (2025). The effect of dolutegravir on obstetrical outcomes among women living with HIV: A retrospective cohort study. Journal of obstetrics and gynaecology research. 51(6). e16349–e16349.
2.
Wasmann, Roeland E., Helen McIlleron, Regina Oladokun, et al.. (2024). Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy. Antimicrobial Agents and Chemotherapy. 68(8). e0035424–e0035424.
3.
Ebonyi, Augustine, Holly Rawizza, Beth Chaplin, et al.. (2024). Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria. Open Forum Infectious Diseases. 11(3). ofae092–ofae092.
4.
Chaplin, Beth, Oche Agbaji, Harry Reyes Nieva, et al.. (2022). Timeliness of Point-of-Care Viral Load Results Improves Human Immunodeficiency Virus Monitoring in Nigeria. Clinical Infectious Diseases. 76(3). e671–e680. 5 indexed citations
5.
Faria, Nuno R., Beth Chaplin, Holly Rawizza, et al.. (2020). Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread. Scientific Reports. 10(1). 3468–3468. 13 indexed citations
6.
Rawizza, Holly, Regina Oladokun, Stephen Oguche, et al.. (2020). Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART. Journal of Antimicrobial Chemotherapy. 76(3). 710–717. 2 indexed citations
7.
Rabie, Helena, Holly Rawizza, Peter Zuidewind, et al.. (2019). Pharmacokinetics of adjusted-dose 8-hourly lopinavir/ritonavir in HIV-infected children co-treated with rifampicin. Journal of Antimicrobial Chemotherapy. 74(8). 2347–2351. 4 indexed citations
8.
Rawizza, Holly, et al.. (2018). INCIDENCE OF ANAEMIA AMONG HIV-INFECTED PATIENTS TREATED WITH ZIDOVUDINE-CONTAINING ANTIRETROVIRAL THERAPY IN NORTHEASTERN NIGERIA.. PubMed. 16(2). 115–124. 6 indexed citations
9.
Chaplin, Beth, Godwin Imade, Chika Onwuamah, et al.. (2017). Distinct Pattern of Thymidine Analogue Mutations with K65R in Patients Failing Tenofovir-Based Antiretroviral Therapy. AIDS Research and Human Retroviruses. 34(2). 228–233. 4 indexed citations
10.
Dugdale, Caitlin M., Sarah Brown, Natalie Wolkow, et al.. (2016). Out of Sight: Culture-Negative Endocarditis and Endophthalmitis. The American Journal of Medicine. 130(2). e51–e53. 3 indexed citations
11.
Meloni, Seema, Beth Chaplin, Charlotte A. Chang, et al.. (2015). Patterns of Adherence and Loss to Follow-Up in Pediatric Patients on ART in Nigeria. Current HIV Research. 13(3). 210–218. 8 indexed citations
12.
Rawizza, Holly, Charlotte A. Chang, Beth Chaplin, et al.. (2015). Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria. Current HIV Research. 13(3). 201–209. 40 indexed citations
13.
Scarsi, Kimberly K., Geoffrey Eisen, Kristin M. Darin, et al.. (2015). Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort. Clinical Infectious Diseases. 62(4). 512–518. 11 indexed citations
14.
Chang, Charlotte A., Seema Meloni, Geoffrey Eisen, et al.. (2015). Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria. Open Forum Infectious Diseases. 2(4). ofv154–ofv154. 22 indexed citations
15.
Meloni, Seema, Charlotte A. Chang, Beth Chaplin, et al.. (2014). Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria. Open Forum Infectious Diseases. 1(2). ofu055–ofu055. 48 indexed citations
16.
Meloni, Seema, Holly Rawizza, Geoffrey Eisen, et al.. (2013). Sputum Smear Concentration May Misidentify Acid-Fast Bacilli As Mycobacterium Tuberculosis in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(2). 168–177. 6 indexed citations
17.
Rawizza, Holly, Beth Chaplin, Seema Meloni, et al.. (2013). Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria. PLoS ONE. 8(9). e73582–e73582. 34 indexed citations
18.
Rawizza, Holly. (2011). Treatment Failure in Children with HIV. Journal watch. 2011. 1 indexed citations
19.
Rawizza, Holly, Beth Chaplin, Seema Meloni, et al.. (2011). Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited Settings. Clinical Infectious Diseases. 53(12). 1283–1290. 117 indexed citations
20.
Rawizza, Holly & Paul E. Sax. (2008). Pharmacokinetic interactions between ritonavir-boosted darunavir and NNRTIs: a report of 3 cases.. PubMed. 18(9). 466–72, 478. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yao Abo Breakdown of academic impact, for papers by Zhongfu Liu Breakdown of academic impact, for papers by Sophie Karcher Breakdown of academic impact, for papers by Khine Wut Yee Kyaw Breakdown of academic impact, for papers by Tinei Shamu Breakdown of academic impact, for papers by Lameck Luwanda Breakdown of academic impact, for papers by Charity Alfredo Breakdown of academic impact, for papers by Boniface Dongmo Nguimfack Breakdown of academic impact, for papers by Fatima Sall Breakdown of academic impact, for papers by K. Naidu
Rankless by CCL
2026